E1A expression dysregulates IL-8 production and suppresses IL-6 production by lung epithelial cells

Respiratory Research

Volumn 6, Issue , 2005, Pages

  van den Berg, Arjen ^a   Snoek, Mieke ^a   Jansen, Henk M ^a   Lutter, René ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

E1A PROTEIN; E1B PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT PROTEIN;

ARTICLE; CELL LINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; WESTERN BLOTTING; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA;

ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; CELL LINE; CLONING, MOLECULAR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; RECOMBINANT PROTEINS; RESPIRATORY MUCOSA;

EID: 26244435603     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-6-111     Document Type: Article

References (30)

1. Fletcher C, Peto R: The natural history of chronic airflow obstruction. Br Med J 1977, 1: 1645-1648.
2. Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies WA, Hogg JC: Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992, 146: 177-184.
3. Elliott WM, Hayashi S, Hogg JC: Immunodetection of adenoviral E1A proteins in human lung tissue. Am J Respir Cell Mol Biol 1995, 12: 642-648.
4. Graham FL, Rowe DT, McKinnon R, Bacchetti S, Ruben M, Branton PE: Transformation by human adenoviruses. J Cell Physiol Suppl 1984, 3: 151-163.
5. Keicho N, Elliott WM, Hogg JC, Hayashi S: Adenovirus E1A upregulates interleukin-8 expression induced by endotoxin in pulmonary epithelial cells. Am J Physiol 1997, 272: L1046-L1052.
6. Keicho N, Elliott WM, Hogg JC, Hayashi S: Adenovirus E1A gene dysregulates ICAM-1 expression in transformed pulmonary epithelial cells. Am J Respir Cell Mol Biol 1997, 16: 23-30.
7. Higashimoto Y, Elliott WM, Behzad AR, Sedgwick EG, Takei T, Hogg JC et al.: Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells. Am J Respir Crit Care Med 2002, 166: 200-207.
8. Vitalis TZ, Kern I, Croome A, Behzad H, Hayashi S, Hogg JC: The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. Eur Respir J 1998, 11: 664-669.
9. van Wissen M, Snoek M, Smids B, Jansen HM, Lutter R: IFN-gamma amplifies IL-6 and IL-8 responses by airway epithelial-like cells via indoleamine 2,3-dioxygenase. J Immunol 2002, 169: 7039-7044.
10. Roger T, Out TA, Jansen HM, Lutter R: Superinduction of interleukin-6 mRNA in lung epithelial H292 cells depends on transiently increased C/EBP activity and durable increased mRNA stability. Biochim Biophys Acta 1998, 1398: 275-284.
11. Roger T, Out T, Mukaida N, Matsushima K, Jansen H, Lutter R: Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem J 1998, 330 ( Pt 1): 429-435.
12. Lutter R, Loman S, Snoek M, Roger T, Out TA, Jansen HM: IL-6 protein production by airway epithelial(-like) cells disabled in IL-6 mRNA degradation. Cytokine 2000, 12: 1275-1279.
13. Janaswami PM, Kalvakolanu DV, Zhang Y, Sen GC: Transcriptional repression of interleukin-6 gene by adenoviral E1A proteins. J Biol Chem 1992, 267: 24886-24891.
14. Bernards R, Schrier PI, Bos JL, Van der Eb AJ: Role of adenovirus types 5 and 12 early region 1b tumor antigens in oncogenic transformation. Virology 1983, 127: 45-53.
15. Zantema A, Fransen JA, Davis-Olivier A, Ramaekers FC, Vooijs GP, DeLeys B et al.: Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology 1985, 142: 44-58.
16. Hacker DL, Bertschinger M, Baldi L, Wurm FM: Reduction of adenovirus E1A mRNA by RNAi results in enhanced recombinant protein expression in transiently transfected HEK293 cells. Gene 2004, 341: 227-234.
17. Lin HJ, Eviner V, Prendergast GC, White E: Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol Cell Biol 1995, 15: 4536-4544.
18. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E: The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A 1992, 89: 7742-7746.
19. Perricaudet M, Akusjarvi G, Virtanen A, Pettersson U: Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses. Nature 1979, 281: 694-696.
20. van den Berg A, Kuiper M, Snoek M, Timens W, Postma DS, Jansen HM ,Lutter R.: Interleukin-17 induces hyperresponsive interleukin-8 and interleukin-6 production to tumor necrosis factor-alpha in structural lung cells. Am J Respir Cell Mol Biol 2005, 33: 97-104.
21. Hierholzer JC, Castells E, Banks GG, Bryan JA, McEwen CT: Sensitivity of NCI-H292 human lung mucoepidermoid cells for respiratory and other human viruses. J Clin Microbiol 1993, 31: 1504-1510.
22. Yang Y, McKerlie C, Borenstein SH, Lu Z, Schito M, Chamberlain JW et al.: Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243- and 289-amino-acid proteins. J Virol 2002, 76: 8910-8919.
23. Spindler KR, Berk AJ: Rapid intracellular turnover of adenovirus 5 early region 1A proteins. J Virol 1984, 52: 706-710.
24. He B, Zhao M, Li X: [Latent adenovirus infection in chronic obstructive pulmonary disease]. Zhonghua Jie He He Hu Xi Za Zhi 2001, 24: 520-523.
25. Tilg H, Dinarello CA, Mier JW: IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997, 18: 428-432.
26. Chen W, Havell EA, Gigliotti F, Harmsen AG: Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infect Immun 1993, 61: 97-102.
27. Bermudez LE, Wu M, Petrofsky M, Young LS: Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect Immun 1992, 60: 4245-4252.
28. Denis M: Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J Leukoc Biol 1992, 52: 197-201.
29. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J: Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol 1991, 138: 1097-1101.
30. Bucchioni E, Kharitonov SA, Allegra L, Barnes PJ: High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med 2003, 97: 1299-1302.